We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. McKesson (MCK - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MCK and the rest of the Medical group's stocks.
McKesson is a member of our Medical group, which includes 898 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. MCK is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for MCK's full-year earnings has moved 2.56% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, MCK has gained about 0.83% so far this year. In comparison, Medical companies have returned an average of -16.46%. As we can see, McKesson is performing better than its sector in the calendar year.
Looking more specifically, MCK belongs to the Medical - Dental Supplies industry, a group that includes 22 individual stocks and currently sits at #45 in the Zacks Industry Rank. This group has lost an average of 13.99% so far this year, so MCK is performing better in this area.
Going forward, investors interested in Medical stocks should continue to pay close attention to MCK as it looks to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. McKesson (MCK - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MCK and the rest of the Medical group's stocks.
McKesson is a member of our Medical group, which includes 898 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. MCK is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for MCK's full-year earnings has moved 2.56% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, MCK has gained about 0.83% so far this year. In comparison, Medical companies have returned an average of -16.46%. As we can see, McKesson is performing better than its sector in the calendar year.
Looking more specifically, MCK belongs to the Medical - Dental Supplies industry, a group that includes 22 individual stocks and currently sits at #45 in the Zacks Industry Rank. This group has lost an average of 13.99% so far this year, so MCK is performing better in this area.
Going forward, investors interested in Medical stocks should continue to pay close attention to MCK as it looks to continue its solid performance.